BioMotiv, a Cleveland, OK-based for-profit therapeutic accelerator, has raised $21m in funding.
Backers include founding investors University Hospitals and the Harrington Family.
The company intends to use the funding to launch operations and initiate the development of its technology portfolio, which is being sourced from leading academic medical centers and industry sources from across the country.
Led by Baiju R. Shah, Chief Executive Officer, BioMotiv is the therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250m initiative announced by University Hospitals this past February.
The company plans to raise a total of $100 million in capital.